Showing 1 - 14 results of 14 for search 'Sanjay Bhagani', query time: 0.05s
Refine Results
-
1
A viewpoint: The 2022 monkeypox outbreak by Pedro Simões, Sanjay Bhagani
Published 2022-06-01
Article -
2
-
3
-
4
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya. by Jeremy Penner, Loice Achieng Ombajo, Davies Otieno, Joseph Nkuranga, Margaret Mburu, Simon Wahome, Anton Pozniak, Sanjay Bhagani
Published 2023-01-01
Article -
5
Highlights from the 24th Conference on Retroviruses and Opportunistic Infections by Trevor A. Crowell, Hermione Lyall, Eva Malatinkova, Sanjay Bhagani, Denise Hsu, Donn J. Colby, Christina Polyak, Christina Psomas, Andrew Hill, Esther N. Gathogo, Wim Trypsteen, Linos Vandekerckhove, Sabie Kinloch
Published 2017-04-01
Article -
6
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study by Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews
Published 2023-10-01
Article -
7
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study. by Huw Price, Loveleen Bansi, Caroline A Sabin, Sanjay Bhagani, Andrew Burroughs, David Chadwick, David Dunn, Martin Fisher, Janice Main, Mark Nelson, Deenan Pillay, Alison Rodger, Chris Taylor, Richard Gilson, UK Collaborative HIV Cohort Hepatitis Group, Steering Committee
Published 2012-01-01
Article -
8
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study by Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Published 2023-09-01
Article -
9
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. by Karin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, Thomas Lutz, Jan Fehr, Mattias Mandorfer, Sanjay Bhagani, Luis F López-Cortés, Annette Haberl, Marcel Stoeckle, Manuel Márquez, Stefan Scholten, Ignacio de Los Santos-Gil, Stefan Mauss, Antonio Rivero, Antonio Collado, Marcial Delgado, Juergen K Rockstroh, Juan A Pineda
Published 2015-01-01
Article -
10
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak. by Vanessa Apea, Boghuma K Titanji, Francesca H Dakin, Rosalie Hayes, Melanie Smuk, Habiba Kawu, Laura Waters, Itsik Levy, Daniel R Kuritzkes, Monica Gandhi, Jürgen Rockstroh, Mauro Schechter, Martin Holt, Romain Palich, Claudia P Cortes, Silvia Nozza, Cristina Mussini, Alexandra Calmy, Brenda E Crabtree-Ramirez, José L Blanco, Sanjay Bhagani, Claire Dewsnap, Chloe Orkin, Mpox SHARE-NET Writing Group
Published 2025-01-01
Article -
11
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C [version 2; peer review: 2 approved] by Graham S. Cooke, Sarah Pett, Leanne McCabe, Chris Jones, Richard Gilson, Sumita Verma, Stephen D. Ryder, Jane D. Collier, Stephen T. Barclay, Aftab Ala, Sanjay Bhagani, Mark Nelson, Chinlye Ch'Ng, Ben Stone, Martin Wiselka, Daniel Forton, Stuart McPherson, Rachel Halford, Dung Nguyen, David Smith, Azim Ansari, Emily Dennis, Fleur Hudson, Eleanor J. Barnes, Ann Sarah Walker
Published 2021-07-01
Article -
12
Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT by Graham S Cooke, Sarah Pett, Leanne McCabe, Christopher Jones, Richard Gilson, Sumita Verma, Stephen D Ryder, Jane D Collier, Stephen T Barclay, Aftab Ala, Sanjay Bhagani, Mark Nelson, Chin Lye Ch’Ng, Benjamin Stone, Martin Wiselka, Daniel Forton, Stuart McPherson, Rachel Halford, Dung Nguyen, David Smith, M Azim Ansari, Helen Ainscough, Emily Dennis, Fleur Hudson, Eleanor J Barnes, Ann Sarah Walker, the STOP-HCV trial team
Published 2021-10-01
Article -
13
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) by Ivan O. Rosas, Norbert Bräu, Michael Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, Sanjay Bhagani, Daniel Skiest, Sinisa Savic, Ivor S. Douglas, Julia Garcia-Diaz, Mariam S. Aziz, Nichola Cooper, Taryn Youngstein, Lorenzo Del Sorbo, David J. De La Zerda, Andrew Ustianowski, Antonio Cubillo Gracian, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Rebecca N. Bauer, Fang Cai, Ivan T. Lee, Balpreet Matharu, Louis Metcalf, Steffen Wildum, Emily Graham, Larry Tsai, Min Bao
Published 2022-05-01
Article -
14
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV by Jeffrey V. Lazarus, Kelly Safreed-Harmon, Adeeba Kamarulzaman, Jane Anderson, Ricardo Baptista Leite, Georg Behrens, Linda-Gail Bekker, Sanjay Bhagani, Darren Brown, Graham Brown, Susan Buchbinder, Carlos Caceres, Pedro E. Cahn, Patrizia Carrieri, Georgina Caswell, Graham S. Cooke, Antonella d’Arminio Monforte, Nikos Dedes, Julia del Amo, Richard Elliott, Wafaa M. El-Sadr, María José Fuster-Ruiz de Apodaca, Giovanni Guaraldi, Tim Hallett, Richard Harding, Margaret Hellard, Shabbar Jaffar, Meaghan Kall, Marina Klein, Sharon R. Lewin, Ken Mayer, Jose A. Pérez-Molina, Doreen Moraa, Denise Naniche, Denis Nash, Teymur Noori, Anton Pozniak, Reena Rajasuriar, Peter Reiss, Nesrine Rizk, Jürgen Rockstroh, Diana Romero, Caroline Sabin, David Serwadda, Laura Waters
Published 2021-07-01
Article